Insulet (PODD) Convertible Debt (2010 - 2011)

Insulet (PODD) reported Convertible Debt of $106.3 million for Q3 2011, up 2.06% quarter-over-quarter from $104.2 million in Q2 2011.

Insulet (PODD) Convertible Debt (2010 - 2011) Analysis & Trends

Insulet has reported Convertible Debt for 2 years, with the latest figure at $106.3 million in Q3 2011.

For the quarter ending Q3 2011, Convertible Debt changed N/A year-over-year to $106.3 million; the trailing twelve-month figure through Sep 2011 stood at $106.3 million (changed N/A YoY), and the FY2010 full-year result was $69.4 million, changed N/A from the prior year.
Convertible Debt for Q3 2011 stood at $106.3 million, up from $104.2 million in the prior quarter.
The five-year high for Convertible Debt was $106.3 million in Q3 2011, with the low at $69.4 million in Q4 2010.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	154.42 Bn	147.76 Bn	6.27 Bn
2	Stryker	118.12 Bn	115.25 Bn	3.81 Bn
3	Medtronic	101.72 Bn	93.55 Bn	5.76 Bn
4	Boston Scientific	67.19 Bn	65.98 Bn	3.61 Bn
5	Edwards Lifesciences	50.69 Bn	47.02 Bn	1.29 Bn
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn
7	Dexcom	28.09 Bn	26.97 Bn	750.30 Mn
8	GE HealthCare Technologies	28.08 Bn	26.02 Bn	1.98 Bn
9	Steris	19.80 Bn	19.37 Bn	697.10 Mn
10	Insulet	10.20 Bn	9.72 Bn	529.10 Mn

Download Data